Abstract
A clinical decision report using
Mantsios A, Murray M, Karver TS, et al. Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials. AIDS Behav. 2020;24(12):3473-3481. https://doi.org/10.1007/s10461-020-02918-x
for a young adult patient struggling with adherence.
DOI
10.22237/crp/1640995440
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
NIRMALAN A. Use of long-acting injectable cabotegravir and rilpivirine as an alternative for treatment in a HIV positive patient. Clin. Res. Prac. Apr 28 2022;8(1):eP2603. https://doi.org/10.22237/crp/1640995440
Included in
Allergy and Immunology Commons, Immune System Diseases Commons, Infectious Disease Commons, Internal Medicine Commons, Primary Care Commons, Social and Behavioral Sciences Commons, Virus Diseases Commons
